Financial statements Przedsiębiorstwo Farmaceutyczne Apexim
Cash flow statement of Przedsiębiorstwo Farmaceutyczne Apexim
Company age:
Age:
23 y. 9 m. 4 d.
Share capital:
Share capital:
10 454 694 PLN
Cash inflows of PRZEDSIĘBIORSTWO FARMACEUTYCZNE APEXIM
|
Year
|
2023
|
|---|---|
| Net cash from operating expenses | 1 370 905,59 |
| Net cash flow from investing activities | -1 190 190,60 |
| Net cash flow from financial activities | -5 937,58 |
| Total net cash flow | 174 777,41 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.